Publications by authors named "Patrick A Burch"

Claim this Profile
E
EUS-guided fine-needle injection of gemcitabine for locally advanced and metastatic pancreatic cancer.
Michael J Levy, Steven R Alberts, William R Bamlet, Patrick A Burch, Michael B Farnell

Gastrointest Endosc· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin Use and Survival of Patients With Pancreatic Cancer: A Cautionary Lesson.
Roongruedee Chaiteerakij, Gloria M Petersen, William R Bamlet, Kari G Chaffee, David B Zhen, Patrick A Burch

J Clin Oncol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for pancreatic neuroendocrine tumors: a clinic-based case-control study.
Thorvardur R Halfdanarson, William R Bamlet, Robert R McWilliams, Timothy J Hobday, Patrick A Burch

Pancreas· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of diabetes mellitus on clinical outcomes in patients undergoing surgical resection for pancreatic cancer: a retrospective, cohort study.
Phil A Hart, Ryan J Law, Ryan D Frank, William R Bamlet, Patrick A Burch

Am J Gastroenterol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma.
Derek R Johnson, David W Kimmel, Patrick A Burch, Terrence L Cascino, Caterina Giannini

Neuro Oncol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic value of clinical and pathologic factors in esophageal adenocarcinoma: a mayo cohort of 796 patients with extended follow-up after surgical resection.
Harry H Yoon, Maliha Khan, Qian Shi, Stephen D Cassivi, Tsung-Teh Wu, Patrick A Burch

Mayo Clin Proc· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obesity adversely affects survival in pancreatic cancer patients.
Robert R McWilliams, Martha E Matsumoto, Patrick A Burch, George P Kim, Thorvardur R Halfdanarson

Cancer· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Older versus younger patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and stomach: a pooled analysis of eight consecutive North Central Cancer Treatment Group (NCCTG) trials.
Aminah Jatoi, Nathan R Foster, James R Egner, Patrick A Burch, Philip J Stella

Int J Oncol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer.
Celestia S Higano, Paul F Schellhammer, Eric J Small, Patrick A Burch, John Nemunaitis

Cancer· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate-specific antigen progression predicts overall survival in patients with metastatic prostate cancer: data from Southwest Oncology Group Trials 9346 (Intergroup Study 0162) and 9916.
Maha Hussain, Bryan Goldman, Cathy Tangen, Celestia S Higano, Daniel P Petrylak, Patrick A Burch

J Clin Oncol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of survival from urachal cancer: a Mayo Clinic study of 49 cases.
Julian R Molina, J Fernando Quevedo, Alfred F Furth, Ronald L Richardson, Horst Zincke, Patrick A Burch

Cancer· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I clinical and pharmacokinetic study of CS-682 administered orally in advanced malignant solid tumors.
Thierry Delaunoit, Patrick A Burch, Joel M Reid, John K Camoriano, Tomowo Kobayash

Invest New Drugs· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life and pain in advanced stage prostate cancer: results of a Southwest Oncology Group randomized trial comparing docetaxel and estramustine to mitoxantrone and prednisone.

J Clin Oncol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of prostate-specific antigen declines for surrogacy in patients treated on SWOG 99-16.
Daniel P Petrylak, Donna Pauler Ankerst, Caroline S Jiang, Catherine M Tangen, Maha H A Hussain, Patrick A Burch

J Natl Cancer Inst· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumors.
Grace K Dy, Ajit Suri, Joel M Reid, Jeff A Sloan, Henry C Pitot, Patrick A Burch

Cancer Chemother Pharmacol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of gemcitabine plus cisplatin in patients with metastatic breast cancer: a North Central Cancer Treatment Group Trial.
Patrick A Burch, James A Mailliard, David W Hillman, Edith A Perez, James E Krook

Am J Clin Oncol· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral administration of a 1,2-dimyristyloxypropyl-3- dimethylhydroxyethyl ammonium bromide/dioleoylphosphatidylethanolamine formulation of the human interleukin-2 gene in the treatment of metastatic renal cell carcinoma.
Evanthia Galanis, Patrick A Burch, Ronald L Richardson, Bradley Lewis, Henry C Pitot

Cancer· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.
Daniel P Petrylak, Catherine M Tangen, Maha H A Hussain, Primo N Lara, Jeffrey A Jones, Patrick A Burch

N Engl J Med· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy (APC8015, Provenge) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: a Phase 2 trial.
Patrick A Burch, Gary A Croghan, Dennis A Gastineau, Lori A Jones, Judith S Kaur

Prostate· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma.
Aminah Jatoi, Neil Ellison, Patrick A Burch, Jeff A Sloan, Shaker R Dakhil

Cancer· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis